期刊
PAIN AND THERAPY
卷 10, 期 2, 页码 1523-1536出版社
SPRINGER INT PUBL AG
DOI: 10.1007/s40122-021-00316-2
关键词
Chronic migraine; OnabotulinumtoxinA; Botox; Patient perspectives; Lived experience; Prophylactic
资金
- Wilderman Medical Clinic
OBT-A is a well-studied prophylactic treatment for chronic migraine, with evidence supporting its effectiveness. This study explored patient experiences and perceptions of OBT-A treatment, revealing common themes among patients who received treatment and those who did not proceed, providing insights into potential barriers to treatment initiation or continuation. Understanding patients' perspectives is crucial for clinical practice and decision-making.
Introduction OnabotulinumtoxinA (OBT-A) is one of the most studied prophylactic treatments for chronic migraine. Large clinical trials, and now real-world studies, continue to provide evidence to support the use of OBT-A as an effective treatment to manage chronic migraine. The objective of this study was to explore patient experience and perception of prophylactic treatment with OBT-A for chronic migraine. Methods Data were collected using semi-structured interviews using open-ended questions to uncover rich descriptive data on patient experiences. Interviews were transcribed and analysed using NVivo data analysis software to code and identify themes across the dataset. Three patient groups were included in the analysis: (1) patients who were receiving continued OBT-A treatment; (2) patients who discontinued OBT-A treatment; (3) patients who were recommended for OBT-A treatment but did not proceed. Results For patients who received at least one OBT-A treatment, four main themes emerged, which described patients' expectations, experiences, and feelings towards their treatment decisions. Two main themes emerged that were common to patients, who had discontinued their treatment and those, who were recommended for OBT-A treatment but did not proceed, which were identified as potential barriers to initiate or continue prophylactic treatment with OBT-A. Conclusion Understanding patients' perspective is an important part of clinical practice and may impact on decision-making. Qualitative data can provide a more holistic view of patient care and treatment insights that may not be evaluated during a clinical trial. This study revealed potential barriers to treatment that can inform future policy and practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据